NEW ENTERPRISE ASSOCIATES 13 LP

CIK 1452907 · last filed 2024-01-31

NEW ENTERPRISE ASSOCIATES 13 LP is a corporate insider who has filed 25 SEC Form 4 insider transactions across 12 companies since 2012. The most recent filing, for SGMT, was dated Jan 31, 2024. Across all open-market trades the lifetime net is +$82.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $880.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$880.49M

Companies

12

Total Filings

25

Lifetime Open-Market Net

$81.98M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SGMT 10%+ Owner 3,000,275 $7.27 $21.81M $2.82M 2 2024-01-31
COUR 10%+ Owner 13,661,886 $5.85 $79.92M $0 2 2021-05-21
SPT 10%+ Owner 3,082,854 $8.69 $26.79M $0 1 2020-11-17
NET 10%+ Owner 2,763,583 $264.10 $729.86M $0 3 2020-11-13
TESARO, Inc. (TSRO) Delisted 10%+ Owner 9,668,495 $20.05M 3 2018-03-06
Care.com Inc (CRCM) Delisted 10%+ Owner 2,256,013 $0 3 2017-11-08
CVENT INC (CVT) Delisted 10%+ Owner 3,994,106 $8.52 $34.03M $0 3 2014-11-28
DERM 10%+ Owner 3,502,922 $6.31 $22.10M $3.32M 1 2014-10-08
Epizyme, Inc. (EPZM) Delisted 10%+ Owner 447,421 $1.47 $657.7K $41.99M 3 2014-08-18
Roka BioScience, Inc. (ROKA) Delisted 10%+ Owner 148,936 $13.80M 1 2014-07-22
Clovis Oncology, Inc. (CLVS) Delisted 10%+ Owner 2,279,781 $0.08 $185.1K $0 1 2013-06-05
WDAY 10%+ Owner 0 $159.69 $0 $0 2 2013-04-11

Recent Filings

25 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-31 SGMT Other (J) −850,000 $0 EDGAR
2023-07-20 SGMT Mixed +22,875,594 $2.88M EDGAR
2021-05-21 COUR Other (J) −4,553,828 $0 EDGAR
2021-04-05 COUR Conv (C) +53,666,142 $0 EDGAR
2020-11-17 SPT Other (J) −2,500,000 $0 EDGAR
2020-11-13 NET Mixed $0 EDGAR
2020-08-10 NET Mixed −1,295,793 $0 EDGAR
2020-05-21 NET Mixed $0 EDGAR
2018-03-06 TESARO, Inc. (TSRO) Delisted Buy (P) +349,335 $20.05M EDGAR
2017-11-08 Care.com Inc (CRCM) Delisted Other (J) −1,000,000 $0 EDGAR
Showing 110 of 25
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.